Cargando…
Older patients with Hodgkin Lymphoma: Walking the tightrope of efficacy and toxicity
Since its initial description, classical Hodgkin lymphoma (cHL) portends a greatly improved prognosis and the goal of treatment in most patients is cure with minimisation of toxicity from treatment. Outcomes in older patients (>60 years old) lag behind those of their younger counterparts however,...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880490/ https://www.ncbi.nlm.nih.gov/pubmed/36713561 http://dx.doi.org/10.3389/fonc.2022.1017787 |